Sign in Subscribe
COVID-19

Egypt Receives First Batch of AstraZeneca Vaccines Under COVAX Agreement

Strategic Insights

— 2 min read

The Egyptian Ministry of Health and Population announced that the country has received 854,400 doses of the AstraZeneca vaccine against COVID-19. This is the first batch of vaccines to arrive in Egypt under the COVAX agreement, a global initiative to ensure equitable distribution of vaccines. The vaccines will be used to immunize healthcare workers, the elderly, and people with chronic diseases, in accordance with the Ministry's plan to protect these segments of society from the risk of contracting the virus. Egypt is scheduled to receive a total of 40 million doses of the vaccine as part of the agreement.

Key Takeaways:

  • Egypt has received 854,400 doses of the AstraZeneca vaccine under the COVAX agreement, the first batch to arrive in the country.
  • The vaccine has obtained emergency approval from the WHO and the Egyptian Drug Authority (EDA), and has a proven 76% effectiveness in preventing COVID-19.
  • Egypt plans to use the vaccine to immunize healthcare workers, the elderly, and people with chronic diseases.
  • The country is scheduled to receive a total of 40 million doses of the vaccine as part of the agreement.
  • The AstraZeneca vaccine offers 100% protection from moderate and severe cases of COVID-19.
  • Egypt is one of the first African countries to receive the AstraZeneca vaccine.
  • The country has also received vaccine shipments from China and the UAE, with a total of 680,000 doses received so far.
  • The COVAX agreement is co-led by GAVI, the Vaccine Alliance, the World Health Organization (WHO), and the Coalition for Epidemic Preparedness Innovations (CEPI).
  • The agreement aims to ensure equitable distribution of vaccines to countries around the world.

Statistics:

  • 854,400: The number of AstraZeneca vaccine doses received by Egypt under the COVAX agreement.
  • 40 million: The total number of AstraZeneca vaccine doses that Egypt is scheduled to receive as part of the agreement.
  • 76%: The effectiveness of the AstraZeneca vaccine in preventing COVID-19.
  • 100%: The protection offered by the AstraZeneca vaccine against moderate and severe cases of COVID-19.
  • 680,000: The total number of vaccine doses received by Egypt from China and the UAE.
  • ú1.3bn: The amount of aid pledged by the UK to end the COVID-19 pandemic as quickly as possible.
  • ú548m: The amount of funding put by the UK into the COVAX AMC scheme.
  • ú1.65bn: The amount pledged by the UK to GAVI, the Vaccine Alliance, over the next five years.
  • é¼38.5bn: The amount of the 'Team Europe' package to support partner countries in the fight against the coronavirus pandemic.
  • é¼2.2bn: The amount contributed by Team Europe to the COVAX Facility to help secure 1.3 billion doses of vaccination.
  • é¼1.8bn: The amount mobilised by the Team Europe approach in grants, loans and guarantees to help mitigate the impact of the outbreak in Egypt.

Sources:

  • Ministry of Health and Population, Egypt
  • COVAX agreement
  • AstraZeneca
  • World Health Organization (WHO)
  • United Nations Children's Fund (UNICEF)
  • International Alliance for Serums and Vaccines (GAVI)
  • Daily News Egypt
  • SyndiGate Media Inc.
  • European Union Delegation to Egypt
  • UK Government
  • German Government
  • US Embassy in Egypt

Read more